SWK
61
6
M
53
-5
AON
65
3
AMP
70
4
ACN
54
-2
RIG
43
3
OMC
66
-3
AXP
74
4
OI
58
11
BF.B
39
-3
GME
68
-5
AA
82
5
DHI
37
-3
PNW
55
2
DOW
42
2
DLTR
58
-5
CI
52
4
AMGN
38
4
PVH
30
-2
SLG
37
6
SWK
61
6
M
53
-5
AON
65
3
AMP
70
4
ACN
54
-2
RIG
43
3
OMC
66
-3
AXP
74
4
OI
58
11
BF.B
39
-3
GME
68
-5
AA
82
5
DHI
37
-3
PNW
55
2
DOW
42
2
DLTR
58
-5
CI
52
4
AMGN
38
4
PVH
30
-2
SLG
37
6
Financhill
Back

T Rowe Price Capital Appreciation Equity ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
35

TCAF
T Rowe Price Capital Appreciation Equity ETF

Last Price:
$38.22
Seasonality Move:
1.3%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$41.96
Seasonality Move:
0.59%
Sell
35
T Rowe Price Capital Appreciation Equity ETF (TCAF) is a Sell

Is T Rowe Price Capital Appreciation Equity ETF a Buy, Sell or Hold?

  • The current T Rowe Price Capital Appreciation Equity ETF [TCAF] share price is $38.43. The Score for TCAF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • TCAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TCAF Stock Price Chart

What is T Rowe Price Capital Appreciation Equity ETF's stock price today?

  • The T Rowe Price Capital Appreciation Equity ETF share price today is $38.43
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TCAF is experiencing slight buying pressure.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

TCAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.47 Buy
Relative Strength Index (14 RSI): 54.13 Buy
Chaikin Money Flow: 239800 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.8 - 38.52) Buy
Bollinger Bands (100): (36.89 - 38.49) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.47 Buy
Relative Strength Index (14 RSI): 61.08 Buy
Chaikin Money Flow: 587345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.32 - 39.82) Buy
Bollinger Bands (100): (17.72 - 34.64) Buy

TCAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.07 Buy
20-day SMA: 38.27 Buy
50-day SMA: 38.31 Buy
200-day SMA: 35.56 Buy
8-day EMA: 24.14 Buy
20-day EMA: 12.54 Buy
50-day EMA: 5.62 Buy
200-day EMA: 1.49 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.46 Buy
20-day SMA: 37.97 Buy
50-day SMA: 33.51 Buy
200-day SMA: 18.21 Buy
8-day EMA: 24.11 Buy
20-day EMA: 12.41 Buy
50-day EMA: 5.54 Buy
200-day EMA: 1.47 Buy

T Rowe Price Capital Appreciation Equity ETF Earnings Growth & TCAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

T Rowe Price Capital Appreciation Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):